CATX

Perspective Therapeutics, Inc. AMEX

Healthcare ·Medical - Devices ·US · perspectivetherapeutics.com

$3.65

Mkt Cap $268.9M

52w Low $1.96 40.2% of range 52w High $6.16

50d MA $4.63 200d MA $3.64

P/E (TTM) -2.8x

EV/EBITDA 19.0x

P/B 1.4x

Debt/Equity 0.0x

ROE -49.8%

P/FCF -2.1x

RSI (14) —

ATR (14) —

Beta 1.87

50d MA $4.63

200d MA $3.64

Avg Volume 3.5M

About

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 16, 2026	AMC	-0.37	-0.51	-37.8%	5.22	-0.8%	-5.2%	-6.9%	-11.9%	-14.8%	-18.8%	—
Nov 10, 2025	AMC	-0.33	-0.35	-6.1%	2.22	-3.2%	+0.0%	-4.5%	-6.8%	-6.3%	-0.5%	—
Aug 13, 2025	AMC	-0.30	-0.30	+0.0%	3.81	-0.3%	+2.4%	-5.2%	-3.1%	-10.2%	-11.3%	—
May 12, 2025	AMC	-0.28	-0.25	+10.7%	2.51	+4.0%	+1.6%	-13.9%	-4.0%	+4.8%	+8.8%	—
Mar 26, 2025	AMC	-0.26	-0.25	+3.8%	2.27	-1.3%	+1.3%	-3.1%	-6.2%	-13.7%	-9.7%	—
Nov 12, 2024	AMC	-0.21	-0.21	+0.0%	10.67	+0.9%	-6.9%	-16.4%	-26.1%	-34.8%	-36.5%	—
Aug 12, 2024	AMC	-0.21	-0.17	+19.0%	12.09	-9.0%	+5.7%	+10.3%	+15.5%	+11.6%	+17.1%	—
May 15, 2024	AMC	-0.30	-0.20	+33.3%	15.70	+0.0%	-2.5%	+1.9%	+3.8%	+1.3%	-5.1%	—
Feb 15, 2024	AMC	-0.04	-0.02	+50.0%	8.71	-1.3%	+0.8%	+5.1%	+6.7%	+9.1%	+10.2%	—
Nov 14, 2023	AMC	-0.40	-0.40	+0.0%	2.32	+10.8%	+8.6%	+11.6%	+12.1%	+6.5%	+11.2%	—
Aug 11, 2023	AMC	-0.30	-0.40	-33.3%	4.78	-5.2%	-1.7%	-5.2%	-16.3%	-19.2%	-14.0%	—
May 15, 2023	AMC	-0.01	-0.01	+0.0%	6.50	-12.3%	-21.5%	-30.2%	-27.1%	-25.2%	-21.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 20	Wedbush	Maintains	Outperform → Outperform	—	$4.20	$4.58	+9.0%	+8.3%	+10.5%	+12.1%	+7.4%	+7.4%
Mar 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.45	$4.55	+2.2%	-4.7%	-3.6%	+1.6%	-5.2%	-8.5%
Mar 18	B. Riley Securities	Maintains	Buy → Buy	—	$4.95	$5.01	+1.2%	-1.8%	-7.1%	-10.1%	-14.3%	-13.3%
Mar 18	Wedbush	Maintains	Outperform → Outperform	—	$4.95	$5.01	+1.2%	-1.8%	-7.1%	-10.1%	-14.3%	-13.3%
Mar 18	UBS	Maintains	Buy → Buy	—	$4.95	$5.01	+1.2%	-1.8%	-7.1%	-10.1%	-14.3%	-13.3%
Mar 17	RBC Capital	Maintains	Outperform → Outperform	—	$5.22	$5.18	-0.8%	-5.2%	-6.9%	-11.9%	-14.8%	-18.8%
Mar 17	BTIG	Maintains	Buy → Buy	—	$5.22	$5.18	-0.8%	-5.2%	-6.9%	-11.9%	-14.8%	-18.8%
Jan 30	Wedbush	Maintains	Outperform → Outperform	—	$4.26	$4.74	+11.3%	-11.0%	+18.8%	+22.1%	+19.7%	+8.7%
Jan 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.26	$4.74	+11.3%	-11.0%	+18.8%	+22.1%	+19.7%	+8.7%
Jan 13	BTIG	Maintains	Buy → Buy	—	$2.41	$2.44	+1.2%	+4.1%	+8.7%	+2.9%	-3.3%	+0.8%
Nov 21	UBS	Maintains	Buy → Buy	—	$2.12	$2.12	+0.0%	-1.4%	+2.4%	+3.3%	+5.2%	+10.8%
Nov 18	B. Riley Securities	Maintains	Buy → Buy	—	$2.21	$2.18	-1.4%	+3.2%	+4.1%	-4.1%	-5.4%	-1.8%
Oct 13	BTIG	Maintains	Buy → Buy	—	$4.86	$5.20	+7.0%	-0.6%	-0.4%	+2.5%	-2.3%	-7.6%
Oct 3	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.49	$3.53	+1.1%	+4.3%	+1.7%	-0.6%	+10.6%	+10.6%
Sep 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.29	$3.31	+0.6%	-3.0%	+0.3%	-3.6%	-0.9%	-3.0%
Jun 23	Wedbush	Maintains	Outperform → Outperform	—	$3.46	$3.47	+0.3%	+18.8%	+10.4%	+10.1%	+4.6%	+8.7%
Jun 23	B. Riley Securities	Maintains	Buy → Buy	—	$3.46	$3.47	+0.3%	+18.8%	+10.4%	+10.1%	+4.6%	+8.7%
Jun 3	RBC Capital	Maintains	Outperform → Outperform	—	$2.39	$2.44	+2.1%	+29.3%	+31.0%	+30.5%	+38.9%	+35.1%
May 14	Truist	Maintains	Buy → Buy	—	$2.55	$2.54	-0.4%	-15.3%	-5.5%	+3.1%	+7.1%	+11.0%
Apr 7	Truist	Maintains	Buy → Buy	—	$1.80	$1.78	-1.1%	+0.0%	-5.0%	+5.6%	+3.3%	+8.3%
Mar 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.20	$2.16	-1.8%	-3.2%	-10.9%	-6.8%	-10.9%	-18.2%
Mar 27	Wedbush	Maintains	Outperform → Outperform	—	$2.27	$2.24	-1.3%	+1.3%	-3.1%	-6.2%	-13.7%	-9.7%
Mar 27	RBC Capital	Maintains	Outperform → Outperform	—	$2.27	$2.24	-1.3%	+1.3%	-3.1%	-6.2%	-13.7%	-9.7%
Mar 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.45	$2.45	+0.0%	-3.7%	+1.6%	+2.9%	+2.9%	+0.8%
Jan 14	RBC Capital	Maintains	Outperform → Outperform	—	$3.40	$3.40	+0.0%	-5.9%	-3.8%	-7.1%	+0.9%	+3.5%
Nov 25	BofA Securities	Downgrade	Buy → Neutral	—	$3.47	$3.55	+2.3%	+6.3%	+26.8%	+18.7%	+25.4%	+19.6%
Nov 25	RBC Capital	Maintains	Outperform → Outperform	—	$3.47	$3.55	+2.3%	+6.3%	+26.8%	+18.7%	+25.4%	+19.6%
Nov 22	Oppenheimer	Maintains	Outperform → Outperform	—	$3.00	$3.06	+2.0%	+15.7%	+23.0%	+46.7%	+37.3%	+45.0%
Oct 24	Wedbush	Maintains	Outperform → Outperform	—	$11.69	$12.28	+5.0%	+1.7%	-1.4%	+1.9%	+1.5%	-1.9%
Oct 11	Oppenheimer	Maintains	Outperform → Outperform	—	$13.25	$11.50	-13.2%	-4.5%	-7.2%	-5.2%	-1.9%	-8.3%
Aug 16	RBC Capital	Maintains	Outperform → Outperform	—	$13.96	$13.92	-0.3%	-3.4%	+1.4%	+6.1%	+9.7%	+7.6%
Aug 13	Oppenheimer	Maintains	Outperform → Outperform	—	$12.09	$11.00	-9.0%	+5.7%	+10.3%	+15.5%	+11.6%	+17.1%
Jun 18	Oppenheimer	Maintains	Outperform → Outperform	—	$10.34	$10.68	+3.3%	+15.4%	+3.0%	-2.4%	-0.4%	-7.6%
Jun 14	RBC Capital	Maintains	Outperform → Outperform	—	$11.60	$12.90	+11.2%	-7.8%	-10.9%	+2.8%	-8.2%	-13.0%
May 16	Jones Trading	Maintains	Buy → Buy	—	$15.70	$15.70	+0.0%	-2.5%	+1.9%	+3.8%	+1.3%	-5.1%
Apr 9	B. Riley Securities	Maintains	Buy → Buy	—	$14.90	$15.00	+0.7%	+4.0%	+2.0%	-4.7%	-1.3%	+2.7%
Apr 1	Oppenheimer	Maintains	Outperform → Outperform	—	$11.90	$12.50	+5.0%	+7.6%	+22.7%	+21.0%	+19.3%	+24.4%
Mar 19	Oppenheimer	Maintains	Outperform → Outperform	—	$9.65	$11.50	+19.2%	+16.1%	+24.4%	+38.9%	+31.6%	+30.6%
May 19	Oppenheimer	Maintains	Outperform → Outperform	—	$4.74	$4.75	+0.2%	+2.5%	+7.6%	+8.6%	+6.3%	+5.3%
Feb 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.20	$17.90	+4.1%	+2.3%	+1.2%	-5.2%	-3.5%	+2.9%
Nov 8	Maxim Group	Downgrade	Buy → Hold	—	$4.81	$4.90	+1.9%	-7.9%	-18.9%	-19.8%	-14.8%	-18.3%